Articles

The new therapeutic imperative in cancer management: Sequence, biosimulate, treat.

The Cancer Letter,

Cellworks Biosimulation Identifies which NSCLC Patients will Benefit from Combining Chemotherapy with Immunotherapy

BioSpace,

Cellworks Biosimulation Predicts Chemotherapy Benefit in Osimertinib-treated NSCLC Patients with EGFR Mutations

FirstWord Pharma,

Cellworks Aims to Validate Clinical Decision Support Capabilities of Computational Model

Precision Medicine Online,

Engineering-level molecular diagnosis: A necessity for cancer treatment—and for a successful Moonshot

The Cancer Letter,

Biosimulation Company Cellworks Launches Precision Oncology-Focused Drug Development Business

Inside Precision Medicine,

Cellworks Singula™ therapy response index (TRI) predicts clinical outcomes for esophageal adenocarcinoma: myCare-004

Journal of Clinical Oncology,

Predictions of overall survival (OS) and progression-free survival (PFS) for specific therapeutic interventions in newly diagnosed glioblastoma multiforme (GBM) using Cellworks Singula™ : myCare-024-04.

Journal of Clinical Oncology,

Cellworks Singula™ TRI Predicts Personalized Treatment Outcomes for Esophageal Adenocarcinoma Patients Beyond Standard Clinical Factors

Biospace,

Cellworks Singula™ TRI Provides Personalized OS and PFS Predictions for 18 NCCN Guideline GBM Therapies

Biospace,

Cellworks Singula™ TRI Predicts Personalized Treatment Outcomes for Esophageal Adenocarcinoma Patients Beyond Standard Clinical Factors

Healthcare Report,

Cellworks Singula™ TRI Provides Personalized OS and PFS Predictions for 18 NCCN Guideline GBM Therapies

Molecular Lab IT,

Cellworks: Personalizing Cancer Treatments Through Therapy Biosimulation Technology

The Healthcare Insights,

Cellworks Omics Biology Model (CBM) to predict therapy response and identify biomarkers for all- trans retinoic acid (ATRA) benefit as addition to induction chemotherapy in adults with acute myeloid leukemia (AML)

Journal of Clinical Oncology,

Cellworks Singula™ Accurately Predicts Clinical Outcome from Treatments in Patients with NSCLCPersonalized Therapy Biosimulation Using Multi-Omic Data Predicts OS and PFS for NSCLC Patients

BioSpace,

Cellworks Singula™ Delivers Superior OS and DFS Predictions for Brain Cancer Patients in myCare-022-03 Clinical Trial

International Business Times,

Study: Advanced multi-omics platform predicts superior OS and DFS for in glioblastoma

The Cancer Letter,

Cellworks Singula(TM) Delivers Superior OS and DFS Predictions for Brain Cancer Patients in myCare-022-03 Clinical Trial

MarketWatch ,

Cellworks CBM Clinical Study Identifies Novel Biomarkers for ATRA Benefit and Failure in AML Patients

BioSpace,

Moving Oncology Beyond
‘One Mutation, One Drug’

Clinical Omics,

myCare Clinical Studies Show Cellworks Singula™ Achieves Superior Therapy Response Predictions for Brain Cancer Patients

Brain Tumor Research,

myCare Clinical Studies Show Cellworks Singula™ Achieves Superior Therapy Response Predictions for Brain Cancer Patients

Chicago Daily Herald,

myCare Clinical Studies Show Cellworks Singula™ Achieves Superior Therapy Response Predictions for Brain Cancer Patients

Boston Herald,

myCare Clinical Studies Show Cellworks Singula™ Achieves Superior Therapy Response Predictions for Brain Cancer Patients

UK Biotech,

Superior therapy response predictions for patients with acute myeloid leukemia (AML) using Cellworks Singula: MyCare-009-01

MDLinx,

Superior therapy response predictions for patients with glioblastoma (GBM) using Cellworks Singula: MyCare-009-03.

Journal of Clinical Oncology,

Superior therapy response predictions for patients with acute myeloid leukemia (AML) using Cellworks Singula: MyCare-009-01

Journal of Clinical Oncology,

Superior therapy response predictions for patients with pancreatic cancer (PDAC) using Cellworks Singula: MyCare-009-05

Journal of Clinical Oncology,

Superior therapy response predictions for patients with pancreatic cancer (PDAC) using Cellworks Singula: MyCare-009-05

Research Gate,

Cellworks - Ideal Treatment Selection with a Computer Predictor

Silicon India,

Cellworks AI - Driven Modeling System Can Help Predict Response to AML, MDS Therapies

GenomeWeb,

Big Data And Virtualization In Precision Medicine

Businessworld,

Combating Cancer Smartly

The Enterprise of Healthcare,

Precision Medicine analytically combines therapies for individualized treatment results : Taher Abbasi

Healthworld,

US-based Life Sciences Technology Company for Precision Medicine, Cellworks Focusing to Expand in India

Businessworld,

Making Cancer Care Personal

University of Iowa,

UF medical students use personalised medicine to catch cancer before it starts

University of Florida Health,

To tailor cancer treatment: Study uses computer simulation to model patient cancer DNA

University of Florida Health,

STAY INFORMED

Top